EMEA-000452-PIP02-10-M06
Key facts
| Invented name |
|
| Active substance |
tadalafil
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0376/2020
|
| PIP number |
EMEA-000452-PIP02-10-M06
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of pulmonary arterial hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|